How Cost-Effective Is Recommendation for Tdap in Adults?
The CDC’s Advisory Committee on Immunization Practice recommends one-time tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) for adults aged 19 years and older, but questions have been raised about cost-effectiveness. A new study finds cost-effectiveness lower than expected but cautions about the dangers of pertussis. Here are more details.
|